Cargando…

A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression

BACKGROUND: Aberrant expression of A20 has been reported in several human malignancies including hepatocellular carcinoma (HCC). However, its clinical relevance and potential role in HCC remain unknown. METHODS: Quantitative PCR, Western blots and immunohistochemistry analyses were used to quantify...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haiyang, Hu, Liang, Luo, Zaili, Zhang, Jian, Zhang, Cunzhen, Qiu, Bijun, Dong, Liwei, Tan, Yexiong, Ding, Jin, Tang, Shanhua, Shen, Feng, Li, Zhong, Wang, Hongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634191/
https://www.ncbi.nlm.nih.gov/pubmed/26538215
http://dx.doi.org/10.1186/s12943-015-0454-6
_version_ 1782399310658273280
author Chen, Haiyang
Hu, Liang
Luo, Zaili
Zhang, Jian
Zhang, Cunzhen
Qiu, Bijun
Dong, Liwei
Tan, Yexiong
Ding, Jin
Tang, Shanhua
Shen, Feng
Li, Zhong
Wang, Hongyang
author_facet Chen, Haiyang
Hu, Liang
Luo, Zaili
Zhang, Jian
Zhang, Cunzhen
Qiu, Bijun
Dong, Liwei
Tan, Yexiong
Ding, Jin
Tang, Shanhua
Shen, Feng
Li, Zhong
Wang, Hongyang
author_sort Chen, Haiyang
collection PubMed
description BACKGROUND: Aberrant expression of A20 has been reported in several human malignancies including hepatocellular carcinoma (HCC). However, its clinical relevance and potential role in HCC remain unknown. METHODS: Quantitative PCR, Western blots and immunohistochemistry analyses were used to quantify A20 expression in HCC samples and cell lines. The correlation of A20 expression with clinicopathologic features was analyzed in a cohort containing 143 patients with primary HCC. Kaplan-Meier curves were used to evaluate the association between A20 expression and patient survival. Functional studies were performed to determine the effects of A20 on proliferation and metastasis of HCC cells in vitro and in vivo. RESULTS: Expression of A20 was increased in HCC tissues and cell lines. Increased expression of A20 was negatively correlated with the tumor size, TNM stage, tumor thrombus formation, capsular invasion and serum AFP levels. Patients with higher A20 expression had a prolonged disease-free survival and overall survival than those with lower A20 expression. Forced expression of A20 significantly inhibited the proliferative and invasive properties of HCC cells both in vitro and in vivo, whereas knockdown of A20 expression showed the opposite effects. Further studies revealed that expression of A20 was inversely correlated with Twist1 levels and NF-κB activity in HCC tissues and cell lines. A20-induced suppression of proliferation and migration of HCC cells were mainly mediated through inhibition of Twist1 expression that was regulated at least partly by A20-induced attenuation of NF-κB activity. CONCLUSIONS: Our results demonstrate that A20 plays a negative role in the development and progression of HCC probably through inhibiting Twist1 expression. A20 may serve as a novel prognostic biomarker and potential therapeutic target for HCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0454-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4634191
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46341912015-11-06 A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression Chen, Haiyang Hu, Liang Luo, Zaili Zhang, Jian Zhang, Cunzhen Qiu, Bijun Dong, Liwei Tan, Yexiong Ding, Jin Tang, Shanhua Shen, Feng Li, Zhong Wang, Hongyang Mol Cancer Research BACKGROUND: Aberrant expression of A20 has been reported in several human malignancies including hepatocellular carcinoma (HCC). However, its clinical relevance and potential role in HCC remain unknown. METHODS: Quantitative PCR, Western blots and immunohistochemistry analyses were used to quantify A20 expression in HCC samples and cell lines. The correlation of A20 expression with clinicopathologic features was analyzed in a cohort containing 143 patients with primary HCC. Kaplan-Meier curves were used to evaluate the association between A20 expression and patient survival. Functional studies were performed to determine the effects of A20 on proliferation and metastasis of HCC cells in vitro and in vivo. RESULTS: Expression of A20 was increased in HCC tissues and cell lines. Increased expression of A20 was negatively correlated with the tumor size, TNM stage, tumor thrombus formation, capsular invasion and serum AFP levels. Patients with higher A20 expression had a prolonged disease-free survival and overall survival than those with lower A20 expression. Forced expression of A20 significantly inhibited the proliferative and invasive properties of HCC cells both in vitro and in vivo, whereas knockdown of A20 expression showed the opposite effects. Further studies revealed that expression of A20 was inversely correlated with Twist1 levels and NF-κB activity in HCC tissues and cell lines. A20-induced suppression of proliferation and migration of HCC cells were mainly mediated through inhibition of Twist1 expression that was regulated at least partly by A20-induced attenuation of NF-κB activity. CONCLUSIONS: Our results demonstrate that A20 plays a negative role in the development and progression of HCC probably through inhibiting Twist1 expression. A20 may serve as a novel prognostic biomarker and potential therapeutic target for HCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0454-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-04 /pmc/articles/PMC4634191/ /pubmed/26538215 http://dx.doi.org/10.1186/s12943-015-0454-6 Text en © Chen et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chen, Haiyang
Hu, Liang
Luo, Zaili
Zhang, Jian
Zhang, Cunzhen
Qiu, Bijun
Dong, Liwei
Tan, Yexiong
Ding, Jin
Tang, Shanhua
Shen, Feng
Li, Zhong
Wang, Hongyang
A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title_full A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title_fullStr A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title_full_unstemmed A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title_short A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
title_sort a20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of twist1 expression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634191/
https://www.ncbi.nlm.nih.gov/pubmed/26538215
http://dx.doi.org/10.1186/s12943-015-0454-6
work_keys_str_mv AT chenhaiyang a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT huliang a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT luozaili a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT zhangjian a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT zhangcunzhen a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT qiubijun a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT dongliwei a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT tanyexiong a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT dingjin a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT tangshanhua a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT shenfeng a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT lizhong a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression
AT wanghongyang a20suppresseshepatocellularcarcinomaproliferationandmetastasisthroughinhibitionoftwist1expression